In:
Journal of Liver Cancer, Korean Liver Cancer Association, Vol. 21, No. 2 ( 2021-09-30), p. 181-186
Abstract:
Hepatocellular carcinoma (HCC) with distant metastasis is an absolute contraindication for liver transplantation (LT). However, it is still unclear whether LT is feasible or acceptable in such patients, albeit after being treated with a multidisciplinary approach and after any metastatic lesion is ruled out. We report one such successful treatment with living donor LT (LDLT) after completely controlling far-advanced HCC with inferior vena cava tumor thrombosis and multiple lung metastases. The patient has been doing well without HCC recurrence for eight years since LDLT. The current patient could be an anecdotal case, but provides a case for expanding LDLT indications in the context of advanced HCC and suchlike.
Type of Medium:
Online Resource
ISSN:
2288-8128
,
2383-5001
DOI:
10.17998/jlc.2021.09.08
Language:
English
Publisher:
Korean Liver Cancer Association
Publication Date:
2021
detail.hit.zdb_id:
3110212-8
Permalink